Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-041946
Filing Date
2021-10-28
Accepted
2021-10-28 20:18:18
Documents
2
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2852
2 EX-24 DOCUMENT attachment1.htm EX-24 4531
  Complete submission text file 0000899243-21-041946.txt   8764
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Primiano Christopher Brett (Reporting) CIK: 0001603510 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40971 | Film No.: 211360098